Alx Oncology Holdings annual operating margin
2018
2019
2020
Alx Oncology Holdings's operating margin was −3,693.99% for fiscal 2020.
View full Alx Oncology Holdings company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2020 | 2020-12-31 | −3,693.99% | −3294.01 pp |
| 2019 | 2019-12-31 | −399.98% | +262.04 pp |
| 2018 | 2018-12-31 | −662.02% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q3 2020 | 2020-09-30 | −1,861.29% | −1537.82 pp |
| Q2 2020 | 2020-06-30 | −2,046.87% | — |
| Q1 2020 | 2020-03-31 | −800.31% | — |
| Q3 2019 | 2019-09-30 | −241.56% | — |
| Q2 2019 | 2019-06-30 | −323.47% | — |
Across the available reported history, Alx Oncology Holdings's operating margin decreased from −399.98% to −3,693.99%, a change of −3294.01 percentage points. The latest reported quarter, Q3 2020, shows −1,861.29%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Alx Oncology Holdings filings at SEC.gov ↗